| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $17.9M | — | +30.7% |
| Cost of Revenue | $16.5M | — | +41.9% |
| Gross Profit | $1.4M | — | -32.6% |
| R&D Expense | $0 | — | -100.0% |
| SG&A Expense | $1.8M | — | +21.7% |
| Operating Income | -$2.2M | — | -162.2% |
| Interest Expense | $423K | — | +126.2% |
| Pre-tax Income | -$2.8M | — | -242.9% |
| Income Tax | $0 | — | — |
| Net Income | -$2.8M | — | -242.9% |
| EPS (Basic) | -$0.06 | — | -100.0% |
| EPS (Diluted) | -$0.06 | — | -100.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $515K | -28.1% | — |
| Short-term Investments | $34K | -25.9% | +35.4% |
| Accounts Receivable | $18.2M | -7.3% | +27.6% |
| Inventory | $5.7M | -2.2% | +19.3% |
| Current Assets | $36.9M | -3.9% | +32.5% |
| Total Assets | $62.4M | -4.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.1M | — | -472.7% |
| Capital Expenditures | $11K | — | -9.0% |
| Investing Cash Flow | -$709K | — | -9929.2% |
| Financing Cash Flow | $348K | — | -38.0% |
| Free Cash Flow | -$1.1M | — | -442.4% |
| +9.1% |
| Current Liabilities | $34.1M | -11.0% | +28.2% |
| Long-term Debt | $3.5M | -8.6% | -28.9% |
| Total Liabilities | $42.5M | -9.6% | +36.2% |
| Stockholders' Equity | $19.8M | +7.6% | -23.6% |